Teva Pharmaceutical advertising spend, FY2025

Teva Pharmaceutical (TEVA) reported $309M of advertising expense for the fiscal year ended Dec 31, 2025. That is 1.8% of revenue of $17.3B. Up 19.3% from FY2024.

Ad spend, FY2025
$309M
year ended Dec 31, 2025
Change vs prior year
+19.3%
vs FY2024
Share of revenue
1.8%
of $17.3B revenue
Rank by ad spend
#167
of 336 companies

Key facts

  • Ad spend is 1.4x its FY2020 level ($225M), faster than revenue (1.0x).
  • The highest year on file is FY2012 at $337M; FY2025 is 8% below it.
  • Largest increase +143.7% in FY2009; largest cut -31.7% in FY2022.
  • Ad spend has risen 2 years in a row.
  • Ad spend is 1.8% of revenue, up from 1.4% in FY2020.
  • Teva Pharmaceutical spends more on advertising than 50% of the 336 US-listed companies tracked. Its ad-to-revenue ratio is below the median of 5.2%.

Ad spend by fiscal year

$0 $100M $200M $300M $400M FY2008 (ended 2008-12-31): $87M FY2009 (ended 2009-12-31): $212M 2009 FY2010 (ended 2010-12-31): $243M FY2011 (ended 2011-12-31): $248M 2011 FY2012 (ended 2012-12-31): $337M FY2013 (ended 2013-12-31): $321M 2013 FY2016 (ended 2016-12-31): $312M FY2017 (ended 2017-12-31): $318M 2017 FY2018 (ended 2018-12-31): $256M FY2019 (ended 2019-12-31): $213M 2019 FY2020 (ended 2020-12-31): $225M FY2021 (ended 2021-12-31): $246M 2021 FY2022 (ended 2022-12-31): $168M FY2023 (ended 2023-12-31): $162M 2023 FY2024 (ended 2024-12-31): $259M FY2025 (ended 2025-12-31): $309M 2025 $309M

Ad spend as % of revenue

0.0% 0.5% 1.0% 1.5% 2.0% FY2008 (ended 2008-12-31): 0.8% FY2009 (ended 2009-12-31): 1.3% 2009 FY2010 (ended 2010-12-31): 1.5% FY2011 (ended 2011-12-31): 1.4% 2011 FY2012 (ended 2012-12-31): 1.7% FY2013 (ended 2013-12-31): 1.6% 2013 FY2016 (ended 2016-12-31): 1.4% FY2017 (ended 2017-12-31): 1.5% 2017 FY2018 (ended 2018-12-31): 1.4% FY2019 (ended 2019-12-31): 1.3% 2019 FY2020 (ended 2020-12-31): 1.4% FY2021 (ended 2021-12-31): 1.5% 2021 FY2022 (ended 2022-12-31): 1.1% FY2023 (ended 2023-12-31): 1.0% 2023 FY2024 (ended 2024-12-31): 1.6% FY2025 (ended 2025-12-31): 1.8% 2025 1.8%

History

Download CSV
Fiscal year Period end Ad spend YoY Revenue Ad / revenue Tag Filing
FY2025 Dec 31, 2025 $309M +19.3% $17.3B 1.8% AdvertisingExpense 10-K Feb 3, 2026
FY2024 Dec 31, 2024 $259M +59.9% $16.5B 1.6% AdvertisingExpense 10-K Feb 3, 2026
FY2023 Dec 31, 2023 $162M -3.6% $15.8B 1.0% AdvertisingExpense 10-K Feb 3, 2026
FY2022 Dec 31, 2022 $168M -31.7% $14.9B 1.1% AdvertisingExpense 10-K Feb 5, 2025
FY2021 Dec 31, 2021 $246M +9.3% $15.9B 1.5% AdvertisingExpense 10-K Feb 12, 2024
FY2020 Dec 31, 2020 $225M +5.6% $16.7B 1.4% AdvertisingExpense 10-K Feb 10, 2023
FY2019 Dec 31, 2019 $213M -16.8% $16.9B 1.3% AdvertisingExpense 10-K Feb 9, 2022
FY2018 Dec 31, 2018 $256M -19.5% $18.3B 1.4% AdvertisingExpense 10-K Feb 10, 2021
FY2017 Dec 31, 2017 $318M +1.9% $21.9B 1.5% AdvertisingExpense 10-K Feb 21, 2020
FY2016 Dec 31, 2016 $312M n/a $21.9B 1.4% AdvertisingExpense 10-K Feb 19, 2019
FY2013 Dec 31, 2013 $321M -4.7% $20.3B 1.6% AdvertisingExpense 20-F Feb 10, 2014
FY2012 Dec 31, 2012 $337M +35.9% $20.3B 1.7% AdvertisingExpense 20-F Feb 10, 2014
FY2011 Dec 31, 2011 $248M +2.1% $18.3B 1.4% AdvertisingExpense 20-F Feb 10, 2014
FY2010 Dec 31, 2010 $243M +14.6% $16.1B 1.5% AdvertisingExpense 20-F Feb 12, 2013
FY2009 Dec 31, 2009 $212M +143.7% $16.1B 1.3% AdvertisingExpense 20-F Feb 17, 2012
FY2008 Dec 31, 2008 $87M n/a $11.1B 0.8% AdvertisingExpense 20-F Feb 15, 2011

What the figure is

Advertising costs as disclosed in the annual report (XBRL tag AdvertisingExpense).

Compared with similar spenders

The 6 companies closest to Teva Pharmaceutical in latest-year ad spend.

Rank Company Ad spend Ad / revenue YoY Fiscal year
164 Celsius $319M 12.7% +43.9% FY2025
165 Hasbro $317M 5.9% -0.8% FY2025
166 Elanco Animal Health $314M 6.7% +33.1% FY2025
167 Teva Pharmaceutical $309M 1.8% +19.3% FY2025
168 Abercrombie & Fitch $308M 5.9% +13.9% FY2026
169 Zoetis $308M 3.3% +2.0% FY2025
170 Truist Financial $299M 1.5% +11.6% FY2025

Full ranking of 336 companies · Biggest increases #77

Questions

How much does Teva Pharmaceutical spend on advertising?

Teva Pharmaceutical spent $309M on advertising in fiscal 2025, the year ended Dec 31, 2025, according to its 10-K filed Feb 3, 2026.

What percentage of revenue does Teva Pharmaceutical spend on advertising?

1.8% of revenue in fiscal 2025 ($309M of $17.3B). The median across the 336 companies tracked is 5.2%.

Is Teva Pharmaceutical spending more on advertising?

Yes. Ad spend rose 19.3% in fiscal 2025 from fiscal 2024. It has risen 2 years in a row.

How does Teva Pharmaceutical rank by advertising spend?

#167 of 336 US-listed companies with $100M or more in ad spend, ranked on each company's latest fiscal year.

What does Teva Pharmaceutical's advertising figure include?

Advertising costs as disclosed in the annual report (XBRL tag AdvertisingExpense).

Source

Filing
10-K for FY2025, filed Feb 3, 2026
Accession number
0001193125-26-034532
Company
TEVA PHARMACEUTICAL INDUSTRIES LTD, CIK 818686, SIC 2834 (Pharmaceutical Preparations)
Data
SEC EDGAR XBRL company facts, retrieved Nov 4, 2026. Methodology.
Cite
Teva Pharmaceutical advertising spend, FY2008-FY2025. Aleksei Trudov, io.trudov.com, from SEC EDGAR XBRL company facts (latest: 10-K filed Feb 3, 2026), retrieved Nov 4, 2026. https://io.trudov.com/company/teva-pharmaceutical-industries/advertising-spend/
Download
CSV, all years · CSV, all 336 companies